Over the last 40 years, Besins Healthcare has discovered, developed and delivered healthcare solutions to help women successfully manage the often-unexpected issues related to pregnancy, infertility and menopause. Our estrogen-based and progesterone-based products are confidently prescribed by physicians in more than 100 countries worldwide. Plus, our recent expansion into contraception aims to provide women with a contraceptive that minimises hormone exposure without compromising efficacy. Find out more below.

Contraception

Our innovative oral contraception offering delivers the first progestogen-only pill in Australia with a 24-hour missed pill window[1]Slinda (drospirenone) Product Information accessed July 2021.

BRAND NAME:

Slinda®

DESCRIPTION: A Progestogen-only pill containing 4 mg drospirenone

Menopausal Hormone Therapy (MHT)

We are a major player in Menopausal Hormone Therapy (MHT), being the first company to develop a transdermal estradiol gel in the seventies and the first to develop a micronised natural progesterone formulation that’s bioavailable by the oral route of administration.

BRAND NAME:

Estrogel Pro®

DESCRIPTION:
A co-pack containing one pack of Estrogel and one pack of Prometrium

DOWNLOAD LINKS

PATIENT INFORMATIONPRODUCT SUPPORTARTG SUMMARY

BRAND NAME:

Estrogel®

DESCRIPTION:
Pump pack containing transdermal estradiol gel

DOWNLOAD LINKS

PATIENT INFORMATIONPRODUCT SUPPORTARTG SUMMARYCONSUMER MEDICINE INFORMATIONPRODUCT INFORMATION

BRAND NAME:

Prometrium®

DESCRIPTION:
Soft-gel oral capsules containing micronised progesterone

DOWNLOAD LINKS

PATIENT INFORMATIONPRODUCT SUPPORTARTG SUMMARYCONSUMER MEDICINE INFORMATIONPRODUCT INFORMATION

Fertility (ART) and Pregnancy Support

Assisted Reproductive Technology (ART), Preterm Birth Prevention and Threatened Miscarriage are core areas of focus for Besins Healthcare.

BRAND NAME:

Utrogestan®

DESCRIPTION:
Soft-gel vaginal capsules containing micronised progesterone

UTROGESTAN FOR TREATMENT OF THREATENED MISCARRIAGE[2]Utrogestan® (micronised progesterone) Product Information updated 22nd February 2022†^

In women with ≥3 previous miscarriages, or women with <3 miscarriages who have a reduced chance of future pregnancy.[2]Utrogestan® (micronised progesterone) Product Information updated 22nd February 2022

^Benefit of treatment was greatest in women with ≥3 previous miscarriages.[2]Utrogestan® (micronised progesterone) Product Information updated 22nd February 2022

FIND OUT MORE

UTROGESTAN PBS LISTED FOR PREVENTATION OF PRETERM BIRTH[2]Utrogestan® (micronised progesterone) Product Information updated 22nd February 2022*

*In women with singleton pregnancy who have a short cervix (midtrimester sonographic cervix ≤25 mm) and/or a history of spontaneous preterm birth.[2]Utrogestan® (micronised progesterone) Product Information updated 22nd February 2022

FIND OUT MORE

UTROGESTAN FOR LUTERAL PHASE SUPPORT IN ART CYCLES[2]Utrogestan® (micronised progesterone) Product Information updated 22nd February 2022

FIND OUT MORE

Watch the insertion video

Access the latest evidence

Access expertise from key opinion leaders in the areas of Menopausal Hormone Therapy, Contraception and Pregnancy Support – delivering both scientific and practical knowledge for your day-to-day patient discussions.

Patient Support

Your resource for patient support materials, for both men and women.